PMID: 8958926Oct 31, 1996Paper

A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12

Annals of the New York Academy of Sciences
A L AngiolilloG Tosato

Abstract

We have developed a nude mouse model in which tumor regression is reproducibly induced by coinjection with or intratumor inoculation of EBV-immortalized B cells. A wide spectrum of tumor-derived human cell lines can be established as subcutaneous tumors in sublethally irradiated athymic mice. Most of these tumors are induced to regress by human B cells immortalized with EBV. The tumor regression process is characterized by superficial necrosis and scarring that progressively extends itself to involve all or most of the tumor. Microscopically, tumor regression is characterized by tumor tissue necrosis, evidence of vascular damage with intimal thickening and capillary thrombosis, and macrophage, but not lymphocyte or neutrophil, infiltration. Profiles of cytokine expression differed between progressive and regressive Burkitt's tumors in that regressive tumors expressed larger levels of TNF-alpha, IL-6, IFN-gamma, IP-10, Mig, and IL-12 p35, but not other chemokines/cytokines. IP-10 and IL-12 were found to act as potent inhibitors of angiogenesis in vivo. IL-12 is an inducer of IFN-gamma and indirectly of IP-10, an IFN-gamma-inducible protein, raising the possibility that the antiangiogenic effect of IL-12 is mediated by IP-10. Pre...Continue Reading

References

Mar 15, 1977·International Journal of Cancer. Journal International Du Cancer·K NilssonG Klein
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·F CozzolinoD M Stern
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D J GoodN P Bouck
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G MüllerW Birchmeier
Oct 1, 1987·The Journal of Experimental Medicine·A D Luster, J V Ravetch
Jan 15, 1988·International Journal of Cancer. Journal International Du Cancer·V E GurtsevitchG M Lenoir
Jan 28, 1986·Biochemistry·H K KleinmanG R Martin
Mar 1, 1987·The Journal of Cell Biology·R FrieselT Maciag
May 27, 1982·Nature·S Taylor, J Folkman
Apr 19, 1995·Journal of the National Cancer Institute·E E VoestJ Folkman
Jul 1, 1995·The Journal of Experimental Medicine·A L AngiolilloG Tosato
Nov 1, 1995·The Journal of Experimental Medicine·F LiaoJ M Farber
Sep 1, 1993·The Journal of Experimental Medicine·A D Luster, P Leder
Apr 15, 1993·Biochemical and Biophysical Research Communications·J M Farber

❮ Previous
Next ❯

Citations

Oct 10, 1998·International Journal of Cancer. Journal International Du Cancer·S DiasF Balkwill
May 18, 1999·International Journal of Cancer. Journal International Du Cancer·K B Pham-NguyenS H Chen
Dec 31, 1998·Springer Seminars in Immunopathology·G TosatoE S Jaffe
Feb 28, 1998·Immunologic Research·G Trinchieri
Mar 28, 2003·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Weidong ZhangHongtao Zeng
Jul 18, 2008·Cancer Immunology, Immunotherapy : CII·Markus LoefflerJohn C Reed
Oct 8, 2005·Angiogenesis·Charlotta Dabrosin
Aug 25, 2007·Cancer Metastasis Reviews·James E TalmadgeEric Scholar
Dec 19, 2007·Cancer Metastasis Reviews·Douglas M NoonanAdriana Albini
Apr 13, 2010·Clinical & Experimental Metastasis·Adriana AlbiniUlrich Pfeffer
Dec 21, 2000·Current Oncology Reports·T R TennantW M Stadler
Mar 25, 2004·Trends in Immunology·Paola RomagnaniSergio Romagnani
Oct 3, 1999·Veterinary Immunology and Immunopathology·B S PhillipsS C Helfand
Jun 6, 2003·Cancer Detection and Prevention·D BisacchiA Albini
May 9, 2000·Critical Reviews in Oncology/hematology·M Hagedorn, A Bikfalvi
Dec 23, 2003·The International Journal of Biochemistry & Cell Biology·Petr BusekAleksi Sedo
Jan 1, 1997·Molecular Medicine Today·P R Colville-Nash, D A Willoughby
Mar 20, 2002·Cytokine & Growth Factor Reviews·Mario P Colombo, Giorgio Trinchieri
Mar 20, 2002·Cytokine & Growth Factor Reviews·Alain P Vicari, Christophe Caux
Mar 20, 2002·Cytokine & Growth Factor Reviews·Hiroaki IkedaRobert D Schreiber
Dec 18, 2002·Cytokine & Growth Factor Reviews·Andrei Thomas-Tikhonenko, Christopher A Hunter
Apr 5, 2001·Trends in Immunology·I MeleroJ Prieto
Oct 12, 2002·Paediatric Respiratory Reviews·John W Wilson, Colin F Robertson
Aug 26, 1998·The British Journal of Surgery·D A McNamaraD J Bouchier-Hayes
Jul 5, 2001·Neuropathology and Applied Neurobiology·S H GoldbergE Lavi
Jul 3, 2004·DNA and Cell Biology·Shu-Yuan YangJian-Ning Zhang
Feb 1, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·N BozkurtA Ayhan
Jul 27, 2006·International Journal of Hematology·Wendy B BernsteinRobert Yarchoan
Mar 4, 2000·Journal of Neurosurgery·F DiMecoA Olivi
Nov 14, 2013·Archivum Immunologiae Et Therapiae Experimentalis·Agnieszka CiomberMagdalena Jarosz
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K J O'ByrneA L Harris
Feb 12, 2014·Cancer Immunology, Immunotherapy : CII·Witold LasekMarek Jakobisiak
Jul 6, 2010·Radiation and Environmental Biophysics·Wei YangJian-Ping Cao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
C SgadariG Tosato
Proceedings of the National Academy of Sciences of the United States of America
Barbara J Muller-BorerNadia N Malouf
Journal of the National Cancer Institute
© 2021 Meta ULC. All rights reserved